Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sanofi 2 ADR Representing Ord Shs SNY

Healthcare
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood... see more

Recent & Breaking News (NDAQ:SNY)

KADMON HOLDINGS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kadmon Holdings, Inc. - KDMN

PR Newswire September 21, 2021

SHAREHOLDER ALERT: WeissLaw LLP Investigates Kadmon Holdings, Inc.

PR Newswire September 10, 2021

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kadmon Holdings, Inc.

PR Newswire September 9, 2021

SHAREHOLDER ALERT: WeissLaw LLP Investigates Translate Bio, Inc.

PR Newswire August 3, 2021

Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer

PR Newswire June 4, 2021

Sanofi and Merck's first and only six-in-one pediatric combination vaccine now available in the United States

PR Newswire June 1, 2021

Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T

GlobeNewswire May 11, 2021

Sanofi establishes three-year collaboration with Stanford Medicine to accelerate immunology research

PR Newswire May 6, 2021

Sanofi to help manufacture Moderna COVID-19 vaccine, supporting global supply demands

PR Newswire April 26, 2021

FDA approves Sarclisa® (isatuximab-irfc) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma

PR Newswire March 31, 2021

Promising Oncology Breakthroughs Sparking Wave of Next Generation of Brain Cancer Therapies

Livemoney February 24, 2021

Biond Biologics and Sanofi Enter into Global Licensing Agreement for BND-22, a Novel Immune Checkpoint Inhibitor Targeting the ILT2 Receptor

PR Newswire January 12, 2021

Canadians living with multiple sclerosis find support during COVID-19 pandemic through dedicated social media network

Canada NewsWire December 8, 2020

Sanofi and the Parkinson's Foundation collaborate to advance the availability of free genetic testing and counseling for people with Parkinson's disease

PR Newswire October 21, 2020

(PRNB) Alert: Johnson Fistel Investigates Proposed Sale of Principia Biopharma; Is $100 a Fair Price?

PR Newswire September 12, 2020

Sanofi Genzyme continues research to improve the lives of patients with multiple sclerosis, with new data presented at MSVirtual2020

PR Newswire September 9, 2020

Biopharma Leaders Unite to Stand with Science

GlobeNewswire September 8, 2020

(PRNB) Alert: Johnson Fistel Investigates Proposed Sale of Principia Biopharma; Are Shareholders Getting a Fair Price?

GlobeNewswire August 18, 2020

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Principia Biopharma Inc. (Nasdaq - PRNB)

ACCESSWIRE IA August 17, 2020

PRINCIPIA BIOPHARMA INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

GlobeNewswire August 17, 2020